Recruiting

Community Services Navigation to Advance Health Equity in Breast Cancer Screening

The goal of this study is to evaluate if adding community services navigation to the standard referral process for social needs is an effective and scalable strategy for addressing disparities in follow-up to abnormal breast cancer screening results. The investigators will determine the effectiveness of social needs referrals combined with a community services navigation intervention in the screening mammography setting to improving breast screening outcomes in underserved women.

I'm interested View official listing
ClinicalTrials.gov IDNCT06305312
PhaseNA
Enrollment1450
SponsorUniversity of Utah
Age18 Years and older
SexALL
I'm interested View official listing

Conditions studied

Breast Cancer

About this study

The goal of this study is to evaluate if adding community services navigation to the standard referral process for social needs is an effective and scalable strategy for addressing disparities in follow-up to abnormal breast cancer screening results. The investigators will determine the effectiveness of social needs referrals combined with a community services navigation intervention in the screening mammography setting to improving breast screening outcomes in underserved women.

Interventions

Primary outcomes

Eligibility information

Inclusion Criteria: * English and Spanish speakers * Received an abnormal result of a screening mammogram * Self-reports at least one social need on the B-SINCERE Screener Exclusion Criteria: * Patients who are currently in treatment for breast cancer * Patients with a normal screening result. * Patients who do not exhibit at least 1 social need according to their SINCERE screening result. * Patients who don't speak English or Spanish * Cognitive limitations that impede informed consent * Patients living outside of Utah

Study locations

Before you participate: Varda Clinical is an independent discovery tool, not the study sponsor or a medical provider. Eligibility can only be determined by the official study team. Discuss potential risks and benefits with a qualified healthcare professional.

Source: ClinicalTrials.gov. Record last refreshed by Varda Clinical: 2026-11-06.